United States · FDA National Drug Code directory
glyburide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65841-832_0450d056-3523-44c3-a4cf-f4557e520ce5
- Product NDC
- 65841-832
- Form
- TABLET
- Composition / generic term
- glyburide
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160602
- Source listing expiry
- 20261231
Source-listed ingredients
- GLYBURIDE — 1.25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (65841-832-01) · 65841-832-01
- 500 TABLET in 1 BOTTLE (65841-832-05) · 65841-832-05
- 30 TABLET in 1 BOTTLE (65841-832-06) · 65841-832-06
- 1000 TABLET in 1 BOTTLE (65841-832-10) · 65841-832-10
- 90 TABLET in 1 BOTTLE (65841-832-16) · 65841-832-16
- 10 BLISTER PACK in 1 CARTON (65841-832-77) / 10 TABLET in 1 BLISTER PACK (65841-832-30) · 65841-832-77
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →